FDA NDC Directory · JSON-LD · Markdown

NEOSTIGMINE METHYLSULFATE

NDC 51662-1557 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerHF Acquisition Co LLC, DBA HealthFirst
Marketing categoryAbbreviated NDA (generic) · App ANDA209933
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsNEOSTIGMINE METHYLSULFATE (1 mg/mL)
Marketing started20210614
Package count1

External sources

Source: openFDA. Public-domain (CC0).